Update on the treatment of hypothyroidism

about

Unstable Thyroid Function in Older Adults Is Caused by Alterations in Both Thyroid and Pituitary Physiology and Is Associated with Increased Mortality.Oral liquid levothyroxine solves the problem of tablet levothyroxine malabsorption due to concomitant intake of multiple drugs.

P2860

Q50269966-BB30D691-EAC7-4B30-B170-B40AD09A02F9 Q53532399-18051258-9638-42CC-A1D7-D9F558201E81

P2860

Update on the treatment of hypothyroidism

Item

http://www.wikidata.org/entity/Q36425038

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Update on the treatment of hypothyroidism

@ast

Update on the treatment of hypothyroidism

@en

type

Item

label

Update on the treatment of hypothyroidism

@ast

Update on the treatment of hypothyroidism

@en

prefLabel

Update on the treatment of hypothyroidism

@ast

Update on the treatment of hypothyroidism

@en

P1476

Update on the treatment of hypothyroidism

@en

P2860

Integration of Peripheral and Glandular Regulation of Triiodothyronine Production by Thyrotropin in Untreated and Thyroxine-Treated Subjects

Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement

Differences in hypothalamic type 2 deiodinase ubiquitination explain localized sensitivity to thyroxine.

Long-Term Outcomes Following Therapy in Differentiated Thyroid Carcinoma: NTCTCS Registry Analysis 1987-2012

The Colorado thyroid disease prevalence study.

Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III).

Thyroxine prescription in the community: serum thyroid stimulating hormone level assays as an indicator of undertreatment or overtreatment.

Metformin and low levels of thyroid-stimulating hormone in patients with type 2 diabetes mellitus.

Thyroxine-triiodothyronine combination therapy versus thyroxine monotherapy for clinical hypothyroidism: meta-analysis of randomized controlled trials.

Effect of UGT1A1, UGT1A3, DIO1 and DIO2 polymorphisms on L-thyroxine doses required for TSH suppression in patients with differentiated thyroid cancer

P304

18-25

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/CCO.0000000000000242

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jacqueline Jonklaas

P577

2015-11-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26544166

http://www.w3.org/2001/XMLSchema#string

P932

4699420

http://www.w3.org/2001/XMLSchema#string

Update on the treatment of hypothyroidism

about

P2860

P2860

Update on the treatment of hypothyroidism

description

name

type

label

prefLabel

P1433

P1476

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932